DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 2, 2005; DOI: 10.1124/dmd.105.007807


0090-9556/06/3403-389-397$20.00
DMD 34:389-397, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.007807v1
34/3/389    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anand, S. S.
Right arrow Articles by Bruckner, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anand, S. S.
Right arrow Articles by Bruckner, J. V.

ONTOGENY OF HEPATIC AND PLASMA METABOLISM OF DELTAMETHRIN IN VITRO: ROLE IN AGE-DEPENDENT ACUTE NEUROTOXICITY

Sathanandam S. Anand, Kyu-Bong Kim, Stephanie Padilla, Srinivasa Muralidhara, Hyo J. Kim, Jeffrey W. Fisher, and James V. Bruckner

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia (S.S.A., K.-B.K, S.M., H.J.K., J.V.B.); Department of Environmental Health Science, School of Public Health, University of Georgia, Athens, Georgia (J.W.F.); Cellular and Molecular Branch, Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina (S.P.); and Pharmacology Department, National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, South Korea (K.-B.K.)

Deltamethrin (DLM) is a relatively potent and widely used pyrethroid insecticide. Inefficient detoxification has been proposed to be the primary reason for the greater sensitivity of immature rats to the acute neurotoxicity of DLM. The objective of this study was to test this hypothesis by characterizing the age dependence of DLM metabolism in vitro, as well as toxic signs and blood levels of the neurotoxic parent compound following administration of 10 mg DLM/kg p.o. in glycerol formal. Metabolism was quantified in vitro by monitoring the disappearance of the parent compound from plasma [via carboxylesterases (CaEs)] and liver microsomes [via CaEs and cytochromes P450 (P450s)] obtained from 10-, 21-, and 40-day-old male Sprague-Dawley rats. Mean (±S.E.) intrinsic clearances (Vmax/Km) in these respective age groups by liver P450s (4.99 ± 0.32, 16.99 ± 1.85, and 38.45 ± 7.03) and by liver CaEs (0.34 ± 0.05, 1.77 ± 0.38, and 2.53 ± 0.19) and plasma CaEs (0.39 ± 0.06, 0.80 ± 0.09, and 2.28 ± 0.56) increased significantly (p ≤ 0.05) with age, because of progressive increases in Vmax. Intrinsic clearance of DLM by plasma CaEs and liver P450s reached adult levels by 40 days, but clearance by liver CaEs did not. Hepatic P450s played the predominant role in DLM biotransformation in young and adult rats. The incidence and severity of neurotoxic effects varied inversely with age. Correspondingly, blood DLM areas under the concentration versus time curve (AUCs) and Cmax values progressively decreased with increasing age. Internal exposure to DLM (blood AUCs) was closely correlated with toxic signs (salivation and tremors). The present study provides evidence that the limited metabolic capacity of immature rats contributes to elevated systemic exposure and ensuing neurotoxic effects of DLM.


Address correspondence to: Sathanandam S. Anand, Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602. E-mail: sanand{at}rx.uga.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Alcorn, F. A. Elbarbry, M. Z. Allouh, and P. J. McNamara
Evaluation of the Assumptions of an Ontogeny Model of Rat Hepatic Cytochrome P450 Activity
Drug Metab. Dispos., December 1, 2007; 35(12): 2225 - 2231.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.